Recommended Reading on Myopia Management:

Brennan NA, Cheng X. Commonly Held Beliefs About Myopia That Lack a Robust Evidence Base. Eye Contact Lens 2019;45:215-25.

Brennan NA, Cheng X, Bullimore MA. Adult Myopia Progression. Invest Ophthalmol Vis Sci 2024;65:49.

Brennan NA, Cheng X, Toubouti Y, Bullimore MA. Efficacy in Myopia Control. Prog Retin Eye Res 2021;83:100923.

Brennan NA, Nixon AD, Cheng X, Bullimore MA. Can we really distinguish 'responders' from 'non-responders' to myopia control interventions? Ophthalmic Physiol Opt 2024;44:1363-7.

Brennan NA, Shamp W, Maynes E, Cheng X, Bullimore MA. Influence of age and race on axial elongation in myopic children: a systematic review and meta-regression. Optom Vis Sci 2024;101:497-507.

Bullimore MA, Brennan NA. Juvenile-Onset Myopia—Who to Treat and How to Evaluate Success? Eye (Lond) 2023 https://doi.org/10.1038/s41433-023-02722-6.

Bullimore MA, Brennan NA. The underestimated role of myopia in uncorrectable visual impairment in the United States. Sci Rep 2023;13:15283.

Bullimore MA, Brennan NA. Efficacy in myopia control-The impact of rebound. Ophthalmic Physiol Opt 2025;45:100-10.

Bullimore MA, Brennan NA. Myopia: An Ounce of Prevention is Worth a Pound of Cure. Ophthalmic Physiol Opt 2022;43:116-121.

Bullimore MA, Jong M, Brennan NA. Myopia control: Seeing beyond efficacy. Optom Vis Sci 2024;101:134-42.

Bullimore MA, Ritchey ER, Shah S, Leveziel N, Bourne RRA, Flitcroft DI. The risks and benefits of myopia control. Ophthalmology 2021;128:1561-1579

Bullimore MA, Richdale K. Myopia Control 2020: Where are we and where are we heading? Ophthal Physiol Opt 2020;40:254–270.

Bullimore MA, Richdale K. Incidence of Corneal Adverse Events in Children Wearing Soft Contact Lenses. Eye Contact Lens 2023;49:204-11.

Bullimore MA, Johnson L. Overnight orthokeratology. Cont Lens Anterior Eye 2020;43:322-32.

Bullimore MA, Brennan NA. Myopia control–why every diopter matters. Optom Vis Sci 2019;96:463-465.

Chamberlain P, Lazon de la Jara P, Arumugam B, Bullimore MA. Axial Length Targets for Myopia Control. Ophthalmic Physiol Opt, 2021;41:523-531.

COMET Group. Myopia Stabilization and Associated Factors among Participants in the Correction of Myopia Evaluation Trial (COMET). Invest Ophthalmol Vis Sci 2013;54:7871-84.

Haarman AEG, Enthoven CA, Tideman JWL, et al. The Complications of Myopia: A Review and Meta-Analysis. Invest Ophthalmol Vis Sci 2020;61:49.

Hu Y, Ding X, Guo X, et al. Association of Age at Myopia Onset with Risk of High Myopia in Adulthood in a 12-Year Follow-up of a Chinese Cohort. JAMA Ophthalmology 2020.

Li X, Huang Y, Liu C, et al. Myopia control efficacy of spectacle lenses with highly aspherical lenslets: results of a 5-year follow-up study. Eye Vis (Lond) 2025;12:10.

Modjtahedi BS, Abbott RL, Fong DS, et al. Reducing the Global Burden of Myopia by Delaying the Onset of Myopia and Reducing Myopic Progression in Children: The Academy's Task Force on Myopia. Ophthalmology 2021;128:816-26.

National Academies of Sciences E, Medicine. Myopia: Causes, Prevention, and Treatment of an Increasingly Common Disease. Washington, DC: The National Academies Press; 2024.

Tideman JW, Snabel MC, Tedja MS, et al. Association of Axial Length with Risk of Uncorrectable Visual Impairment for Europeans with Myopia. JAMA Ophthalmology 2016;134:1355-63.

Ueda E, Yasuda M, Fujiwara K, et al. Trends in the Prevalence of Myopia and Myopic Maculopathy in a Japanese Population: The Hisayama Study. Invest Ophthalmol Vis Sci 2019;60:2781-6.

Walline JJ, Walker MK, Mutti DO, et al. Effect of High Add Power, Medium Add Power, or Single-Vision Contact Lenses on Myopia Progression in Children: The Blink Randomized Clinical Trial. JAMA 2020;324:571-80.

Yam JC, Jiang Y, Tang SM, et al. Low-Concentration Atropine for Myopia Progression (LAMP) Study: A Randomized, Double-Blinded, Placebo-Controlled Trial of 0.05%, 0.025%, and 0.01% Atropine Eye Drops in Myopia Control. Ophthalmology 2019;126:113-24.

Yam JC, Zhang XJ, Zhang Y, et al. Effect of Low-Concentration Atropine Eyedrops vs Placebo on Myopia Incidence in Children: The LAMP2 Randomized Clinical Trial. JAMA 2023;329:472-81.

Zadnik K, Sinnott LT, Cotter SA, et al. Prediction of Juvenile-Onset Myopia. JAMA Ophthalmology 2015;133:683-9.